Radiation Sensitization of HNSCC Cells by the dual PI3K / mTOR Inhibitor BEZ235 as a function of the Cell Cycle

被引：0
|
作者：
Brandt, F. W. [1 ]
Balzer, V [1 ]
Dreffke, K. [1 ]
Wittig, A. [1 ,2 ]
Dikomey, E. [1 ,3 ]
Arenz, A. [1 ]
Schoetz, U. [1 ]
Engenhart-Cabillic, R. [1 ]
机构：
[1] Philipps Univ Marburg, Klin Strahlentherapie & Radioonkol, Marburg, Germany
[2] Univ Klinikum Jena, Klin Strahlentherapie & Radioonkol, Jena, Germany
[3] UKE Hamburg, Lab Strahlenbiol & Expt Radioonkol, Hamburg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2018年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P19-3-jD
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [1] The Dual PI3K/mTOR Inhibitor BEZ235 Is Effective in Lung Cancer Cell Lines
    Herrera, Vivian Arrias
    Zeindl-Eberhart, Evelyn
    Jung, Andreas
    Huber, Rudolf Maria
    Bergner, Albrecht
    ANTICANCER RESEARCH, 2011, 31 (03) : 849 - 854
  • [2] Radiation Sensitization of Head and Neck Tumor Cells using the dual PI3K/mTOR Inhibitor NVP-BEZ235
    Balzer, V.
    Subtil, F.
    Dikomey, E.
    Engenhart-Cabillic, R.
    Schoetz, U.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S233 - S233
  • [3] Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions
    Potiron, Vincent A.
    Abderrhamani, Rym
    Giang, Eric
    Chiavassa, Sophie
    Di Tomaso, Emmanuelle
    Maira, Sauveur-Michel
    Paris, Francois
    Supiot, Stephane
    RADIOTHERAPY AND ONCOLOGY, 2013, 106 (01) : 138 - 146
  • [4] PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
    Chen, Jiezhong
    Shao, Renfu
    Li, Feng
    Monteiro, Michael
    Liu, Jun-Ping
    Xu, Zhi Ping
    Gu, Wenyi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (12): : 1317 - 1326
  • [5] Radiosensitization by the Dual PI3K/mTOR inhibitor NVP-BEZ235
    Cerniglia, George J.
    Karar, Jayashree
    Koumenis, Constantinos
    Maity, Amit
    CANCER RESEARCH, 2012, 72
  • [6] Radiosensitization by the Dual PI3K/mTOR Inhibitor NVP-BEZ235
    Maity, A.
    Cerniglia, G. J.
    Karar, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S84 - S85
  • [7] The dual Inhibitor BEZ235 of the PI3K/mTor-Signaling Pathway enhances the Radiosensitivity of HNSCC-Cells by Inhibiting Double-strand Break Repair
    Arenz, A.
    Balzer, V
    Dreffke, K.
    Wittig, A.
    Rieckmann, T.
    Koecher, S.
    Dikomey, E.
    U, Schoetz
    Engenhart-Cabillic, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S11 - S12
  • [8] Enhanced efficacy of histone deacetylase inhibitor panobinostat combined with dual PI3K/mTOR inhibitor BEZ235 against glioblastoma
    Meng, Wei
    Wang, Baocheng
    Mao, Weiwei
    Wang, Jiajia
    Zhao, Yang
    Li, Qifeng
    Zhang, Chenran
    Ma, Jie
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2019, 81 (01): : 93 - 102
  • [9] Dual PI3K/mTOR Inhibitor BEZ235 combined with BMS-1166 Promoting Apoptosis in Colorectal Cancer
    Liu, Xueke
    Xu, Wei
    Li, Lele
    Zhang, Zhenyong
    Lu, Mei
    Xia, Xiaoping
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (10): : 1814 - 1823
  • [10] The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma
    Gan, Zhen Ying
    Fitter, Stephen
    Vandyke, Kate
    To, Luen B.
    Zannettino, Andrew C. W.
    Martin, Sally K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (04) : 343 - 354
12345